1Woo EY,Chu CS,Goletz TJ,et al.Regulatory CD4 CD25 T cells in tumors from patients with early stage nonsmall cell lung cancer and late stage ovarian cancer(J).Cancer Res,2001;61(12):4766-72.
2Wolf AM,Wolf D,Steurer M,et al.Increase in regulatory T cells in the peripheral blood of cancer patients(J).Clin Cancer Res,2003;9(3):606-12.
3Schaefer C,Gkim G,Albers A.Characteristics of CD4 CD25 regulatory T cell in the peripheral circulations of patients with head and neck cancer(J).BJC,2005;8(1):1-8.
4Liyange UK,Moore TT,Joo HG,et al.Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma(J).Immunology,2002;169(5):2756-61.
7Kim R,Emi M,Tanabe K.Cancer cell immune escape and tumor progres-sion by exploitation of anti-inflammatory and pro-inflammatory responses(J).Cancer Biol Therapy,2005;4(9):924-33.
8Li R,Ruttinger D,Li R,et al.Analysis of the immunological microenvi-ronment at the tumor site in patients with non-small cell lung cancer(J).Langenbecks Arch Surg,2003;388(6):406-12.
9Watkins SK,Egilmez NK,Suttles J,et al.IL-12 rapidly alters the func-tional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo(J).J Immunol,2007;178(3):1357-62.
10Lee YS,Kim JH,Choi KJ,et al.Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine mode(lJ).Clin cancer Res,2006;12(19):5859-68.
1Mojtahedi,-Z. Possible different serum IL-4 levels across popula- tions: a reason for dissimilar incidence of Thl and Th2 diseases. Med-Hypotheses. 2012 Jun; 78(6) : 776 -7.
2A1-Attiyah, -R ; EI-Shazly, -A ; Mustafa, -A-S. Comparative analysis of spontaneous and ycobacterial antigen-induced secretion of Thl, Th2 and pro-inflammatory cytokines by peripheral blood mononucle- ar cells of tuberculosis patients[ J]. Scand-J-Immunol. 2012 Jun; 75(6) : 623 -32.
3Miotto D, Lo Cascio N, Stendardo M, et al. CD8+ T cellsexpressing IL-10 are associated with a favourable prognosisin lung cancer[J]. Lung Cancer, 2010, 69(3): 355-360.
4Grant WB. Does solar ultraviolet irradiation affect cancermortality rates in China?[J]. Asian Pac J Cancer Prev, 2007,8(2): 236-242.
5Mohr SB, Garland CF, Gorham ED, et al. Could ultravio-let B irradiance and vitamin D be associated with lower in-cidence rates of lung cancer?[J]. J Epidemiol CommunityHealth, 2008, 62(1): 69-74.
6Goettel JA, Scott Algood HM, Olivares-Villagomez D, et al.KSR1 protects from interleukin-10 deficiency-induced coli-tis in mice by suppressing T lymphocyte interferon-yproduction[J]. Gastroenterology, 2011, 140(1): 265-274.
7Zeni E, Mazzetti L,Miotto D, et al. Macrophage expres-sion of interleukin-10 is a prognostic factor in nonsmall celllung cancerfJ]. Eur Respir J, 2007,30(4); 627-632.
8Nunzia Tacelli,Teresa Santangelo,Arnaud Scherpereel,Alain Duhamel,Valérie Deken,Ernst Klotz,Alexis Cortot,Jean-Jacques Lafitte,Frédéric Wallyn,Jacques Remy,Martine Remy-Jardin.Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy[J].European Radiology.2013(8)
